Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer [Yahoo! Finance]
Vir Biotechnology, Inc. (VIR)
Company Research
Source: Yahoo! Finance
Medical Officer, Phil Pang, M.D., Ph.D., has decided to leave the company at the end of March 2024 to spend more time with his family. The Company has initiated a search for a successor. "Phil has served as a formidable leader at Vir, where he played a major part in the development of sotrovimab during the peak of the COVID-19 pandemic. With his background in infectious diseases, he has built strong teams with a mission of targeting major unmet needs globally, including chronic hepatitis delta, hepatitis B, and HIV," said Marianne De Backer, M.Sc., Ph.D., MBA, Vir's Chief Executive Officer. "He leaves behind a strong team of drug developers, positioning us well for continued success. I wish him the very best." "I am humbled by all that Vir has accomplished in the last seven years, and it has been an honor to lead such a world-class team of experts. Now, after a period of reflection, I have decided to spend more time with my family," said Dr. Pang. "I leave a very capable developme
Show less
Read more
Impact Snapshot
Event Time:
VIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VIR alerts
High impacting Vir Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
VIR
News
- What Makes Vir Biotechnology (VIR) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of DirectorsBusiness Wire
- Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 [Yahoo! Finance]Yahoo! Finance
- Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024Business Wire
VIR
Earnings
- 2/22/24 - Beat
VIR
Analyst Actions
- 2/23/24 - JP Morgan
VIR
Sec Filings
- 4/19/24 - Form ARS
- 4/19/24 - Form DEFA14A
- 4/19/24 - Form DEF
- VIR's page on the SEC website